Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Averbis is a leading German health-tech company specializing in Artificial Intelligence (AI) and Natural Language Processing (NLP) for the healthcare and life sciences sectors. Founded in 2007 as a spin-off from the University Medical Center Freiburg, the company provides advanced text mining solutions that transform unstructured medical data into structured, actionable insights. Its core platforms, Health Discovery and Information Discovery, are used by hospitals, pharmaceutical companies, and research institutions to automate clinical documentation, accelerate drug discovery, and enhance patient care through data-driven decision-making. Averbis is recognized for its expertise in multilingual information retrieval and its ability to integrate complex medical terminologies like ICD-10 and SNOMED-CT into clinical workflows.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Averbis.